Use of herbal medicinal products among patients in primary health care in a Brazilian southeastern city: evidence from the Prover project.

IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL
Einstein-Sao Paulo Pub Date : 2024-11-08 eCollection Date: 2024-01-01 DOI:10.31744/einstein_journal/2024AO0827
Betania Barros Cota, Jéssica de Castro Alves, Alberto Araújo de Caux, Leila Cristina Ferreira Passagli, Ana Karine Sarvel de Castro, Tatiana Chama Borges Luz
{"title":"Use of herbal medicinal products among patients in primary health care in a Brazilian southeastern city: evidence from the Prover project.","authors":"Betania Barros Cota, Jéssica de Castro Alves, Alberto Araújo de Caux, Leila Cristina Ferreira Passagli, Ana Karine Sarvel de Castro, Tatiana Chama Borges Luz","doi":"10.31744/einstein_journal/2024AO0827","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence and factors associated with herbal medicinal product use among primary healthcare patients in southeastern Brazil.</p><p><strong>Methods: </strong>A cross-sectional study combined with documentary research was conducted between August and November 2017, involving interviews with 1,221 adults following dispensing from primary healthcare units. The characterization of herbal medicinal product usage included assessing the prevalence, redundancy, and interaction indicators, as well as identifying sources of recommendation and acquisition. Descriptive statistics were used for variable analysis and logistic regression was used to estimate the factors associated with herbal medicinal product usage, calculating odds ratios at a significance level of 5%.</p><p><strong>Results: </strong>The prevalence of herbal medicinal product usage was 3.8%, with 60% of them prescribed by physicians. Private pharmacies (53%) were the main sources, and Valeriana officinalis (42%) was the most cited plant species and the sole herbal medicinal product on the municipal list. The indicators of redundancy and interactions between concurrently prescribed pharmaceutical and herbal medicinal products were 42.9% and 28.6%, respectively. Herbal medicinal products usage correlated with the female sex (OR= 2.50; 95%CI= 1.11-5.59), non-white race (OR= 0.52; 95%CI= 0.28-0.94), monthly income above 1 minimum wage (OR= 3.48; 95%CI= 1.51-8.01), and self-reported of anxiety, mood disorder or depression (OR= 2.97; 95%CI= 1.55-5.66).</p><p><strong>Conclusion: </strong>Despite the low use of herbal medicinal products, users face a high potential for interactions and therapeutic redundancy. Special attention should be paid to patients taking herbal medicinal products and allopathic medicines concurrently. Women with anxiety, mood disorders, or depression were more likely to use herbal medicinal products, whereas non-white people were 48% less likely to use them, suggesting potential socioeconomic disparities in access.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Einstein-Sao Paulo","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31744/einstein_journal/2024AO0827","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To determine the prevalence and factors associated with herbal medicinal product use among primary healthcare patients in southeastern Brazil.

Methods: A cross-sectional study combined with documentary research was conducted between August and November 2017, involving interviews with 1,221 adults following dispensing from primary healthcare units. The characterization of herbal medicinal product usage included assessing the prevalence, redundancy, and interaction indicators, as well as identifying sources of recommendation and acquisition. Descriptive statistics were used for variable analysis and logistic regression was used to estimate the factors associated with herbal medicinal product usage, calculating odds ratios at a significance level of 5%.

Results: The prevalence of herbal medicinal product usage was 3.8%, with 60% of them prescribed by physicians. Private pharmacies (53%) were the main sources, and Valeriana officinalis (42%) was the most cited plant species and the sole herbal medicinal product on the municipal list. The indicators of redundancy and interactions between concurrently prescribed pharmaceutical and herbal medicinal products were 42.9% and 28.6%, respectively. Herbal medicinal products usage correlated with the female sex (OR= 2.50; 95%CI= 1.11-5.59), non-white race (OR= 0.52; 95%CI= 0.28-0.94), monthly income above 1 minimum wage (OR= 3.48; 95%CI= 1.51-8.01), and self-reported of anxiety, mood disorder or depression (OR= 2.97; 95%CI= 1.55-5.66).

Conclusion: Despite the low use of herbal medicinal products, users face a high potential for interactions and therapeutic redundancy. Special attention should be paid to patients taking herbal medicinal products and allopathic medicines concurrently. Women with anxiety, mood disorders, or depression were more likely to use herbal medicinal products, whereas non-white people were 48% less likely to use them, suggesting potential socioeconomic disparities in access.

巴西东南部城市基层医疗机构病人使用草药产品的情况:Prover 项目提供的证据。
目的确定巴西东南部初级医疗保健患者使用草药产品的流行率和相关因素:在 2017 年 8 月至 11 月期间开展了一项结合文献研究的横断面研究,在基层医疗机构配药后对 1221 名成年人进行了访谈。草药产品使用特征包括评估流行率、冗余度和交互指标,以及确定推荐和购买来源。描述性统计用于变量分析,逻辑回归用于估算与草药产品使用相关的因素,计算显著性水平为 5%的几率比率:使用草药产品的比例为 3.8%,其中 60% 由医生处方。私立药房(53%)是主要来源,缬草(42%)是被引用最多的植物品种,也是市级名单上唯一的草药产品。同时处方的药品和草药之间的重复和相互作用指标分别为 42.9% 和 28.6%。草药产品的使用与女性性别(OR= 2.50;95%CI= 1.11-5.59)、非白人种族(OR= 0.52;95%CI= 0.28-0.94)、月收入高于最低工资标准(OR= 3.48;95%CI= 1.51-8.01)以及自述焦虑、情绪障碍或抑郁(OR= 2.97;95%CI= 1.55-5.66)相关:尽管草药产品的使用率较低,但使用者面临着发生相互作用和治疗冗余的高度可能性。应特别注意同时服用草药产品和对抗疗法药物的患者。患有焦虑症、情绪障碍或抑郁症的女性更有可能使用草药产品,而非白人使用草药产品的可能性则低 48%,这表明在使用草药产品方面可能存在社会经济差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Einstein-Sao Paulo
Einstein-Sao Paulo MEDICINE, GENERAL & INTERNAL-
CiteScore
2.00
自引率
0.00%
发文量
210
审稿时长
38 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信